Document is current
Any future updates will be listed below
-
Authors
Kern, Simone https://orcid.org/0000-0001-7173-1482
Geiger, Michael
Paucke, Madlen
Kästner, Alina
Akgün, Katja
Ziemssen, Tjalf
-
Funding
Funding for this research was provided by:
Novartis Pharma (xxxx)
- License Information
-
More Information
Article History
Received: 15 March 2019
Revised: 10 July 2019
Accepted: 17 July 2019
First Online: 30 August 2019
Compliance with ethical standards
: Written informed consent was obtained from each participant prior to study entry. The protocol was reviewed and approved by the local ethics committee (TU Dresden, Faculty of Medicine).
: Dr. Kern reports grants from Novartis Pharma GmbH, Germany during the conduct of the study; personal fees from Biogen Idec and personal fees from Teva Pharma, outside the submitted work. M. Geiger reports grants from Novartis Pharma GmbH, Germany during the conduct of the study. Dr. Paucke reports grants from Novartis Pharma GmbH, Germany during the conduct of the study. A. Kästner reports grants from Novartis Pharma GmbH during the conduct of the study. Dr. Ziemssen reports grants from Novartis Pharma GmbH, Germany during the conduct of the study; grants and personal fees from Bayer, grants and personal fees from Biogen, grants and personal fees from TEVA, grants and personal fees from Genzyme, grants and personal fees from Novartis, personal fees from Merck, personal fees from Almirall, personal fees from GSK and personal fees from Roche, outside the submitted work. Dr. Katja Akgün reports personal fee from Biogen Idec, Sanofi, Merck and Roche for oral presentations.
